Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug development for inflammation, pain, and more.
Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug discovery and development with a clinical program.Tetra Bio-Pharma specializes in combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio-pharma industry by regulators, physicians, and insurance companies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 16, 2022 | Post-IPO Debt | $4.50M | 1 | Ministère de l'Économie et de l'Innovation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Ministère de l'Économie et de l'Innovation | Yes | Post-IPO Debt |